• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用肠系膜入路治疗胰腺癌后行麦克基翁食管癌切除术治疗食管癌:一例报告

McKeown Esophagectomy for Esophageal Cancer Following Pancreaticoduodenectomy Using a Mesenteric Approach for Pancreatic Cancer: A Case Report.

作者信息

Miwa Takeshi, Okumura Tomoyuki, Numata Yoshihisa, Fukasawa Mina, Kimura Nana, Watanabe Toru, Hirano Katsuhisa, Hashimoto Isaya, Shibuya Kazuto, Yoshioka Isaku, Onoda Satoshi, Satake Toshihiko, Fujii Tsutomu

机构信息

Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan.

Department of Plastic and Reconstructive Surgery, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan.

出版信息

Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.25-0204. Epub 2025 Sep 3.

DOI:10.70352/scrj.cr.25-0204
PMID:40927229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12414813/
Abstract

INTRODUCTION

There are no reports of patients undergoing McKeown esophagectomy for esophageal cancer after undergoing pancreaticoduodenectomy for pancreatic cancer. We report the case of a patient who underwent subtotal esophagectomy and colon reconstruction after pancreaticoduodenectomy using the mesenteric approach.

CASE PRESENTATION

A 71-year-old male was diagnosed with advanced esophageal cancer. Four years prior to diagnosis, he underwent subtotal stomach-preserving pancreaticoduodenectomy using the mesenteric approach for pancreatic surgery, followed by Child's reconstruction surgery. After undergoing 3 cycles of neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, the patient was scheduled for a subtotal esophagectomy. The middle colic artery was transected using the mesenteric approach, and the upper jejunum was utilized for Child's reconstruction surgery. A 2-stage procedure involving McKeown esophagectomy and left-sided colon reconstruction was planned. The 1st stage of the procedure involved robot-assisted subtotal esophagostomy in the prone position, followed by cervical esophagostomy and gastrostomy. The patient underwent the 2nd stage of the surgery after approximately 1 month of parenteral nutrition via a gastrostomy tube. The transverse colon was mobilized and transected at the hepatic flexure. The left side of the mesocolon, which is fed by the left colic artery, was then pulled up through the antethoracic route. The right internal thoracic artery and vein were anastomosed to the marginal artery and vein of the transverse colon, respectively, for supercharge and superdrainage. Reconstruction involved esophago-colonic and colonic-gastric anastomoses. The patient was discharged without postoperative complications, and no signs of recurrence were observed at the 2-year postoperative follow-up.

CONCLUSIONS

Subtotal esophagectomy for esophageal cancer after subtotal stomach-preserving pancreaticoduodenectomy using a mesenteric approach and colon reconstruction can be safely performed in 2 stages. The optimization of pancreaticoduodenectomy for pancreatic cancer could improve the long-term survival of patients with 2nd primary esophageal cancer, for which radical esophagectomy is necessary.

摘要

引言

目前尚无关于胰腺癌患者接受胰十二指肠切除术后又接受麦克基翁食管癌切除术治疗食管癌的报道。我们报告了一例采用肠系膜入路在胰十二指肠切除术后接受次全食管切除术及结肠重建术的患者。

病例介绍

一名71岁男性被诊断为晚期食管癌。在诊断前四年,他因胰腺手术采用肠系膜入路接受了保留部分胃的胰十二指肠切除术,随后进行了Child式重建手术。在接受多西他赛、顺铂和5-氟尿嘧啶的3个周期新辅助化疗后,该患者计划接受次全食管切除术。采用肠系膜入路切断中结肠动脉,并利用空肠上段进行Child式重建手术。计划进行两阶段手术,包括麦克基翁食管癌切除术和左侧结肠重建术。手术的第一阶段包括在俯卧位进行机器人辅助次全食管造口术,随后进行颈部食管造口术和胃造口术。在通过胃造口管进行大约1个月的肠外营养后,患者接受了手术的第二阶段。游离横结肠并在肝曲处切断。然后将由左结肠动脉供血的结肠系膜左侧通过胸前途径上提。分别将右胸廓内动脉和静脉与横结肠的边缘动脉和静脉吻合,以进行增压和引流。重建包括食管-结肠和结肠-胃吻合。患者术后无并发症出院,术后2年随访未观察到复发迹象。

结论

采用肠系膜入路在保留部分胃的胰十二指肠切除术后行食管癌次全切除术及结肠重建术可安全地分两阶段进行。胰腺癌胰十二指肠切除术的优化可提高需要行根治性食管癌切除术的第二原发性食管癌患者的长期生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58b/12414813/6fb4f8b12b5a/scr-11-01-25-0204-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58b/12414813/56e289528e45/scr-11-01-25-0204-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58b/12414813/56288f100230/scr-11-01-25-0204-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58b/12414813/ad888a838535/scr-11-01-25-0204-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58b/12414813/fce18763a707/scr-11-01-25-0204-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58b/12414813/6fb4f8b12b5a/scr-11-01-25-0204-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58b/12414813/56e289528e45/scr-11-01-25-0204-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58b/12414813/56288f100230/scr-11-01-25-0204-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58b/12414813/ad888a838535/scr-11-01-25-0204-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58b/12414813/fce18763a707/scr-11-01-25-0204-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58b/12414813/6fb4f8b12b5a/scr-11-01-25-0204-g005.jpg

相似文献

1
McKeown Esophagectomy for Esophageal Cancer Following Pancreaticoduodenectomy Using a Mesenteric Approach for Pancreatic Cancer: A Case Report.采用肠系膜入路治疗胰腺癌后行麦克基翁食管癌切除术治疗食管癌:一例报告
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.25-0204. Epub 2025 Sep 3.
2
Postoperative nutritional support after pancreaticoduodenectomy in adults.成人胰十二指肠切除术后的营养支持
Cochrane Database Syst Rev. 2025 Mar 14;3(3):CD014792. doi: 10.1002/14651858.CD014792.pub2.
3
Single-Stage Pedicle Preputial Tube Substitution Urethroplasty with Corpora Cavernosa Augmentation Using Buccal Mucosa Graft for Primary Peno-Scrotal Hypospadias Re-pair in Adults.单阶段带蒂包皮管替代尿道成形术联合阴茎海绵体增大术,采用颊黏膜移植治疗成人原发性阴茎阴囊型尿道下裂修复术
Int Braz J Urol. 2025 Jul-Aug;51(4). doi: 10.1590/S1677-5538.IBJU.2024.0650.
4
Long-term functional outcomes after replacement of the esophagus with gastric, colonic, or jejunal conduits: a systematic literature review.采用胃、结肠或空肠导管替代食管后的长期功能结局:一项系统文献综述
Dis Esophagus. 2017 Dec 1;30(12):1-11. doi: 10.1093/dote/dox083.
5
Radiofrequency ablation of liver metastases in a patient with pancreatic cancer and long-term survival: A case report.胰腺癌患者肝转移灶的射频消融及长期生存:一例报告
World J Clin Cases. 2025 Jul 16;13(20):100169. doi: 10.12998/wjcc.v13.i20.100169.
6
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
7
Laparoscopic Pancreaticoduodenectomy Combined With Portal-Superior Mesenteric Vein Resection and Reconstruction: Inferior-Posterior "Superior Mesenteric Artery-First" Approach.腹腔镜胰十二指肠切除术联合门静脉-肠系膜上静脉切除与重建:下后“肠系膜上动脉优先”入路。
Surg Laparosc Endosc Percutan Tech. 2024 Jun 1;34(3):306-313. doi: 10.1097/SLE.0000000000001288.
8
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
9
Can we improve time to patency with vasoepididymostomy with an innovative epididymal occlusion stitch?我们能否通过一种创新的附睾结扎缝线来改善吻合术的通畅时间?
Int Braz J Urol. 2024 Jul-Aug;50(4):504-506. doi: 10.1590/S1677-5538.IBJU.2024.0222.
10
Robot-assisted cervical esophagectomy with simultaneous transhiatal abdominal procedure for thoracic esophageal carcinoma.机器人辅助颈胸腹三切口食管癌根治术。
Surg Endosc. 2024 Nov;38(11):6413-6422. doi: 10.1007/s00464-024-11214-x. Epub 2024 Sep 3.

本文引用的文献

1
Incidence, mortality, survival, and treatment statistics of cancers in digestive organs-Japanese cancer statistics 2024.消化器官癌症的发病率、死亡率、生存率及治疗统计——2024年日本癌症统计数据
Ann Gastroenterol Surg. 2024 Jun 17;8(6):958-965. doi: 10.1002/ags3.12835. eCollection 2024 Nov.
2
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial.双药化疗、三药化疗或双药化疗联合放疗作为局部晚期食管癌的新辅助治疗(JCOG1109 NExT):一项随机、对照、开放标签、III 期临床试验。
Lancet. 2024 Jul 6;404(10447):55-66. doi: 10.1016/S0140-6736(24)00745-1. Epub 2024 Jun 11.
3
Subtotal esophagectomy and concurrent reconstruction with free jejunal flap for primary esophageal cancer after pancreatoduodenectomy.胰十二指肠切除术后原发性食管癌的食管次全切除术及游离空肠瓣同期重建术。
Surg Case Rep. 2024 May 22;10(1):128. doi: 10.1186/s40792-024-01919-5.
4
Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer.术前新辅助放化疗为可切除边缘的胸段食管癌提供了与临床T3胸段食管癌相当的治疗效果。
Ann Gastroenterol Surg. 2023 Jun 11;7(6):904-912. doi: 10.1002/ags3.12706. eCollection 2023 Nov.
5
Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1.日本食管癌学会编辑的《2022年食管癌诊疗指南》:第1部分。
Esophagus. 2023 Jul;20(3):343-372. doi: 10.1007/s10388-023-00993-2. Epub 2023 Mar 18.
6
Prognostic factors in conversion surgery following nab-paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual-center study.吉西他滨联合纳米白蛋白结合型紫杉醇及后续放化疗用于不可切除局部晚期胰腺癌转化手术的预后因素:一项双中心研究结果
Ann Gastroenterol Surg. 2022 Aug 16;7(1):157-166. doi: 10.1002/ags3.12613. eCollection 2023 Jan.
7
Indocyanine green fluorescence imaging for evaluating blood flow in the reconstructed conduit after esophageal cancer surgery.吲哚菁绿荧光成像用于评估食管癌手术后重建管道中的血流情况。
Surg Today. 2022 Mar;52(3):369-376. doi: 10.1007/s00595-021-02296-4. Epub 2021 May 11.
8
Esophageal reconstruction using a pedicled jejunum following esophagectomy for metastatic esophageal stricture from breast cancer in a patient with previous pancreatoduodenectomy.在一名曾接受过胰十二指肠切除术的患者中,因乳腺癌转移导致食管狭窄而行食管切除术后,采用带蒂空肠进行食管重建。
Nagoya J Med Sci. 2019 Nov;81(4):679-685. doi: 10.18999/nagjms.81.4.679.
9
Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer.局部晚期胸段食管癌的新辅助治疗策略
Ann Gastroenterol Surg. 2019 Mar 1;3(3):269-275. doi: 10.1002/ags3.12243. eCollection 2019 May.
10
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05).吉西他滨与S-1新辅助化疗对比直接手术治疗可切除胰腺癌的随机II/III期试验(Prep-02/JSAP05)
Jpn J Clin Oncol. 2019 Feb 1;49(2):190-194. doi: 10.1093/jjco/hyy190.